SEP 3, 2026 · JOURNAL ARTICLE
The inspiration of CRISPR-Cas: Interface of nature with a pharmacy: A compatible horizon of cancer treatment
Next Nanotechnology
This is a narrative review discussing CRISPR-Cas potential in oncology without reporting empirical data, clinical outcomes, or trial results; it presents conceptual possibilities and technical developments rather than evidence of efficacy.